diseas
known
coronaviru
diseas
potenti
caus
outbreak
sever
acut
respiratori
syndromecoronaviru
wuhan
china
hit
world
hard
led
unpreced
health
econom
crisi
order
develop
treatment
option
abl
stop
amelior
effect
need
understand
biolog
viru
insid
cell
kind
studi
still
scarc
recent
studi
investig
translatom
proteom
host
cell
chang
induc
vitro
present
studi
use
publicli
avail
proteom
data
studi
reanalyz
mechan
alter
viru
infect
impact
pathway
analysi
network
analysi
protein
link
inflammatori
respons
also
protein
relat
chromosom
segreg
mitosi
found
regul
upregul
inflammatoryrel
protein
observ
could
link
propag
inflammatori
reaction
lung
injuri
observ
advanc
stage
patient
diseas
known
coronaviru
diseas
potenti
caus
outbreak
sever
acut
respiratori
syndromecoronaviru
hit
world
hard
initi
report
decemb
chines
citi
wuhan
potenti
link
zoonosi
relat
wild
anim
market
spread
global
rapidli
world
health
organ
declar
pandem
march
th
march
th
confirm
case
confirm
death
countri
affect
wwwwhoint
data
access
march
rd
becom
biggest
health
emerg
centuri
current
neither
effect
treatment
vaccin
main
measur
taken
nation
social
distanc
first
partial
total
prevent
lockdown
afterward
deriv
biggest
global
econom
crisi
also
centuri
typic
clinic
manifest
consist
acut
respiratori
distress
syndrom
fever
dri
cough
difficulti
breath
patient
especi
specif
comorbid
rapidli
worsen
die
although
estim
high
proport
undocu
case
asymptomat
carrier
mild
symptom
patient
test
crude
mortal
ratio
estim
although
consequ
high
rate
covert
case
test
strong
bia
true
mortal
rate
depend
number
diagnost
test
perform
countri
case
present
alarm
level
spread
sever
order
develop
treatment
option
abl
stop
amelior
effect
need
understand
biolog
viru
insid
cell
therefor
urgent
need
deciph
host
cell
molecular
mechan
trigger
viru
infect
instanc
cellular
factor
use
first
step
infect
entri
cell
recent
studi
demonstr
employ
angiotensinconvert
enzym
host
cell
receptor
togeth
serin
proteas
subsequ
inhibitor
propos
treatment
option
hand
also
report
express
protect
lung
injuri
downregul
sarscov
might
promot
lung
injuri
therefor
worsen
prognosi
diseas
demonstr
yet
whether
also
interfer
express
howev
knowledg
go
insid
cell
entri
viru
still
scarc
host
cell
proteom
studi
measur
protein
abund
chang
caus
viru
obtain
global
vision
chang
pathway
network
analysi
shed
light
mechan
use
andor
alter
viru
therefor
target
drug
develop
trial
best
knowledg
first
avail
studi
describ
translatom
proteom
host
cell
chang
induc
one
bojkova
et
al
use
cytoscap
reactomefi
propos
overrepres
pathway
could
target
potenti
treatment
compound
studi
use
publicli
avail
proteom
data
studi
reanalyz
mechan
alter
viru
infect
impact
pathway
analysi
network
analysi
proteom
measur
bojkova
et
al
download
use
subsequ
analysi
data
consist
quantif
protein
human
cell
secretom
four
time
point
infect
viru
accord
author
tmtlabel
bottomup
quantit
proteom
approach
use
obtain
data
high
ph
revers
phase
peptid
fraction
mass
spectrometri
measur
peptid
use
thermo
qexact
nanoliquid
chromatographi
configur
ipathwayguid
advaita
corpor
plymouth
mi
usa
within
pippr
pathway
analysi
framework
cobo
technolog
ap
maaloev
denmark
use
analyz
significantli
impact
pathway
go
analysi
quantifi
protein
includ
analysi
threshold
consid
protein
differenti
express
de
foldchang
higher
pvalu
data
analyz
context
pathway
obtain
kyoto
encyclopedia
gene
genom
kegg
databas
releas
may
ipathwayguid
also
use
network
analysi
use
string
jan
biogrid
mar
data
sourc
interact
includ
activ
bind
catalysi
express
inhibit
confid
score
proteinprotein
interact
set
high
impact
pathway
analysi
ipathwayguid
softwar
calcul
pvalu
use
hypergeometr
distribut
pvalu
adjust
use
fals
discoveri
rate
fdr
affect
pathway
analyz
use
ipathwayguid
softwar
significantli
impact
pathway
accord
analysi
shown
figur
fdr
correct
six
pathway
found
significantli
impact
h
infect
two
h
none
h
h
figur
differenti
express
protein
time
point
present
deepest
chang
infect
subject
network
analysi
use
ipathwayguid
interact
includ
activ
bind
catalysi
express
inhibit
confid
score
proteinprotein
interact
set
high
result
network
shown
figur
one
subnetwork
highest
number
interact
compris
six
protein
shown
figur
togeth
express
chang
profil
postinfect
time
six
protein
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
significantli
affect
pathway
analyz
use
ipathwayguid
softwar
implement
impact
analysi
approach
take
consider
overrepresent
differenti
express
gene
given
pathway
ie
enrich
analysi
also
topolog
inform
direct
type
signal
pathway
posit
role
type
protein
although
six
pathway
found
significantli
impact
h
two
h
number
de
protein
pathway
low
rang
protein
instanc
pathway
transcript
misregul
cancer
de
protein
includ
pathway
proteoglycan
cancer
pathway
de
protein
axon
guidanc
pathway
de
protein
total
protein
thu
consid
experiment
evid
actual
effect
viru
mechan
rel
low
howev
still
low
number
de
protein
ratio
de
protein
total
protein
includ
three
signific
pathway
higher
deserv
closer
look
linol
acid
metabol
pathway
neomycin
kanamycin
gentamicin
biosynthesi
pathway
neuroact
ligandreceptor
interact
pathway
linol
acid
metabol
pathway
link
arachidon
acid
metabol
eicosanoid
pathway
therefor
could
play
role
inflammatori
respons
observ
stage
ii
iii
patient
actual
two
protein
found
de
pathway
h
postinfect
cytosol
phospholipas
phospholipas
membran
associ
key
compon
phospholipas
group
previous
suggest
particip
key
mechan
propag
inflammatori
reaction
demonstr
contribut
inflamm
eicosanoid
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
profil
arthriti
cardiovascular
diseas
check
trend
whole
time
cours
protein
share
profil
clear
increas
h
viru
infect
figur
interest
explor
potenti
two
protein
earli
system
diagnosi
biomark
two
protein
neomycin
kanamycin
gentamicin
biosynthesi
pathway
result
upregul
h
viru
infect
figur
hexokinas
hexokinas
domain
contain
protein
relat
glucos
use
homeostasi
interestingli
hk
previous
associ
inflammatori
respons
autoimmun
disord
deoxydglucos
inhibitor
hk
propos
amelior
autoimmun
inflamm
recent
shown
inhibit
replic
cell
inhibit
rhinoviru
infect
inflamm
murin
model
hexokinas
link
infect
relat
inflamm
respons
deserv
studi
figur
network
form
de
protein
exclud
isol
node
shown
one
subnetwork
higher
number
connect
one
form
sumoprotein
ligas
figur
form
complex
nuclear
pore
cytoplasm
restrict
factor
block
postentri
retrovir
infect
regul
sumo
demonstr
loss
block
sumoyl
suppress
antiretrovir
activ
present
statist
signific
foldchang
log
h
postinfect
therefor
role
coronaviru
infect
deserv
consider
subnetwork
protein
interestingli
relat
cell
cycl
progress
also
deserv
research
figur
aurka
aurkb
particip
regul
chromosom
segreg
mitosi
interestingli
found
downregul
h
postinfect
except
strongli
upregul
subnetwork
close
relat
aurkb
also
downregul
ubiquitinconjug
enzym
c
essenti
factor
anaphas
promot
complexcyclosom
apcc
cell
cycleregul
ubiquitin
ligas
control
progress
mitosi
parallel
reanalyz
data
altern
tool
take
close
look
data
discov
downregul
trend
time
figur
highlight
origin
author
actual
h
time
quantit
present
foldchang
log
pvalu
coronaviru
entri
target
cell
depend
bind
spike
protein
cellular
receptor
facilit
viral
attach
surfac
target
cell
report
entri
receptor
sarscov
anoth
coronaviru
close
relat
play
key
role
sarscov
transmiss
recent
also
also
peptidas
reninangiotensin
system
convert
antiotensin
angiotensin
angiotensin
ii
angiotensin
vasodil
protect
role
lung
injuri
relat
cleavag
angiotensin
ii
regard
sarscov
also
report
express
protect
lung
injuri
downregul
sarscov
might
promot
lung
injuri
therefor
worsen
prognosi
diseas
highlight
seem
also
interf
express
could
relat
higher
level
lung
injuri
demonstr
sarscov
inspect
quantit
data
protein
reninangiotensin
system
two
protein
found
downregul
h
postinfect
cathepsin
ctsa
angiotensinogen
agt
figur
hypothes
dysregul
key
compon
reninangiotensin
system
could
relat
lung
injuri
worsen
observ
summar
work
reanalysi
data
studi
chang
caus
infect
cellular
model
point
sever
protein
mainli
relat
inflammatori
respons
also
anoth
subset
relat
chromosom
segreg
might
modul
infect
case
protein
relat
inflamm
upregul
observ
could
link
propag
inflammatori
reaction
lung
injuri
observ
advanc
stage
patient
